🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 20 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/12/2003 | 55,66 | 55,85 | 52,70 | 52,74 | -4,67% | 5,65% | 161.075 |
| 12/12/2003 | 54,72 | 55,77 | 53,90 | 55,32 | +0,68% | 3,42% | 283.223 |
| 11/12/2003 | 53,64 | 55,40 | 53,45 | 54,95 | +2,73% | 3,63% | 386.270 |
| 10/12/2003 | 53,97 | 54,35 | 51,88 | 53,49 | -0,76% | 4,58% | 242.935 |
| 09/12/2003 | 54,65 | 54,83 | 53,64 | 53,90 | -0,69% | 2,19% | 178.521 |
| 08/12/2003 | 54,50 | 55,02 | 52,63 | 54,27 | +0,14% | 4,40% | 152.419 |
| 05/12/2003 | 54,42 | 54,83 | 53,19 | 54,20 | -1,16% | 3,03% | 164.174 |
| 04/12/2003 | 54,50 | 55,17 | 52,40 | 54,83 | +1,45% | 5,08% | 158.296 |
| 03/12/2003 | 56,11 | 57,04 | 52,40 | 54,05 | -3,28% | 8,27% | 361.396 |
| 02/12/2003 | 51,92 | 56,14 | 51,92 | 55,88 | +6,72% | 8,15% | 504.811 |
| 01/12/2003 | 50,27 | 52,66 | 50,08 | 52,36 | +5,51% | 5,14% | 365.244 |
| 28/11/2003 | 49,71 | 50,19 | 48,58 | 49,63 | -0,08% | 3,24% | 92.413 |
| 26/11/2003 | 49,52 | 49,67 | 48,47 | 49,67 | +0,91% | 2,42% | 73.711 |
| 25/11/2003 | 48,85 | 50,38 | 48,17 | 49,22 | +1,23% | 4,52% | 402.139 |
| 24/11/2003 | 44,92 | 48,77 | 44,88 | 48,62 | +9,90% | 8,67% | 271.521 |
| 21/11/2003 | 45,29 | 45,48 | 44,24 | 44,24 | -1,50% | 2,73% | 435.455 |
| 20/11/2003 | 44,84 | 46,64 | 44,28 | 44,92 | +0,17% | 5,26% | 146.007 |
| 19/11/2003 | 45,33 | 46,23 | 44,35 | 44,84 | +1,70% | 4,13% | 209.298 |
| 18/11/2003 | 45,14 | 45,85 | 43,27 | 44,09 | -1,26% | 5,72% | 569.012 |
| 17/11/2003 | 45,10 | 45,25 | 43,98 | 44,65 | -1,81% | 2,82% | 339.889 |
| 14/11/2003 | 48,55 | 48,66 | 45,33 | 45,48 | -5,45% | 6,86% | 248.091 |
| 13/11/2003 | 48,81 | 48,88 | 47,91 | 48,10 | -0,93% | 1,99% | 112.477 |
| 12/11/2003 | 47,27 | 49,15 | 46,64 | 48,55 | +3,51% | 5,30% | 153.648 |
| 11/11/2003 | 46,82 | 47,54 | 45,51 | 46,90 | +0,97% | 4,32% | 267.888 |
| 10/11/2003 | 49,00 | 49,03 | 46,45 | 46,45 | -5,05% | 5,27% | 196.528 |
| 07/11/2003 | 49,15 | 49,78 | 47,76 | 48,92 | +0,23% | 4,11% | 200.001 |
| 06/11/2003 | 51,47 | 51,47 | 48,70 | 48,81 | -5,16% | 5,38% | 218.248 |
| 05/11/2003 | 50,38 | 51,50 | 49,22 | 51,47 | +2,00% | 4,53% | 113.840 |
| 04/11/2003 | 50,46 | 51,58 | 50,01 | 50,46 | -1,75% | 3,12% | 86.642 |
| 03/11/2003 | 52,06 | 53,15 | 50,49 | 51,35 | -0,44% | 5,10% | 313.707 |